ArriVent Biopharma, Inc. Business Operations Contracts & Agreements
6 Contracts & Agreements
- Collaboration Agreements (5 contracts)
- Indemnification Agreements (1)
- Amended and Restated Research and Collaboration Agreement, dated August 9, 2024, by and between Aarvik Therapeutics, Inc. and the Registrant (Filed With SEC on November 14, 2024)
- Research and Collaboration Agreement Between Jiangsu Alphamab Biopharmaceuticals Co., Ltd and Arrivent Biopharma, Inc (Filed With SEC on August 14, 2024)
- Clinical Collaboration Agreement, by and between the Registrant and Beijing InnoCare Pharma Tech Co., Ltd., dated June 23, 2023 (Filed With SEC on January 5, 2024)
- Research Collaboration Agreement, dated December 21, 2021, by and between Aarvik Therapeutics, Inc. and the Registrant, as amended by Amendment No. 1, effective June 30, 2023 (Filed With SEC on January 5, 2024)
- Joint Clinical Collaboration Agreement, by and between the Registrant and Shanghai Allist Pharmaceuticals Co., Ltd., dated December 24, 2021 (Filed With SEC on January 5, 2024)
- Form of Indemnification Agreement (Filed With SEC on January 5, 2024)
